Sara Cazzaniga
Italfarmaco (Italy)(IT)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Histone Deacetylase Inhibitors Research, Cancer-related Molecular Pathways, Genetic Neurodegenerative Diseases, Neurogenetic and Muscular Disorders Research
Most-Cited Works
- → A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis(2012)261 cited
- → Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2024)103 cited
- → HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle‐resident mesenchymal cells(2020)93 cited
- → Inhibition of RET tyrosine kinase by SU5416(2006)54 cited
- Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats.(1996)
- → Expression, purification, and inhibition of human RET tyrosine kinase(2005)28 cited
- → Muscle histological changes in a large cohort of patients affected with Becker muscular dystrophy(2022)27 cited
- → Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study(2023)19 cited
- → Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration(2019)18 cited
- → Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?(2020)17 cited